Osteoporosis, Age-Related
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Rheumatoid Arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies.
|
12833524 |
2003 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Osteoporosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Osteoporosis, Senile
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Post-Traumatic Osteoporosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Asthma
|
0.110 |
AlteredExpression
|
disease |
BEFREE |
Mice lacking functional NADPH oxidases due to knockout of p47 and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and airway hyperreactivity to inhaled methacholine.
|
23884469 |
2013 |
Asthma
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in Australia.
|
21150878 |
2011 |
Celiac Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Multiple common variants for celiac disease influencing immune gene expression.
|
20190752 |
2010 |
Celiac Disease
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Multiple common variants for celiac disease influencing immune gene expression.
|
20190752 |
2010 |
Multiple Sclerosis
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
|
22190364 |
2011 |
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in GDAP1, YARS, and the pleckstrin homology domain of dynamin 2 lead to an intermediate form of CMT that is characterized by moderately reduced nerve conduction velocity consistent with minor myelin deficits.
|
16856148 |
2006 |
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Dynamin 2 (DNM2)-related dominant centronuclear myopathy is usually a mild disorder, but more severe variants have been associated with mutations affecting the pleckstrin homology (PH) domain of the protein, mainly implicated in different forms of Charcot-Marie-Tooth Disease (CMT).
|
19932620 |
2010 |
Charcot-Marie-Tooth Disease
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
We performed a mutational screening of DNM2 exons 13 through 16 encoding the pleckstrin homology domain in a large series of CMT patients with a broad range of nerve conduction velocities and without mutations in more common genes.
|
17636067 |
2007 |
X-linked agammaglobulinemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Structural basis for pleckstrin homology domain mutations in X-linked agammaglobulinemia.
|
7849006 |
1995 |
X-linked agammaglobulinemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations that cause X-linked agammaglobulinemia (XLA) appear throughout the Bruton tyrosine kinase (Btk) sequence, including the pleckstrin homology (PH) domain.
|
15082835 |
2004 |
X-linked agammaglobulinemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the pleckstrin homology (PH) domain of the Btk gene cause human X-linked agammaglobulinemia (XLA) and murine X-linked immunodeficiency (Xid).
|
8939985 |
1996 |
Malignant neoplasm of breast
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We have performed functional analysis of six non-hotspot AKT1 pleckstrin homology domain mutants identified in recent large-scale breast cancer sequencing studies.
|
23237847 |
2013 |
Malignant neoplasm of breast
|
0.020 |
Biomarker
|
disease |
BEFREE |
Novel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cells.
|
25569504 |
2015 |
Glioblastoma
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.
|
21454620 |
2011 |
Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
PA differs from GBM by the expression of genes related to metabolism (apolipoprotein D), proteolysis (protease-serine-11), receptor and signal transduction (PLEKHB1 for Pleckstrin-Homology-domain-containing-protein-family-B-member-1), transcription/translation (eukaryotic-translation-elongation-factor-1-alpha1) processes and cell adhesion (SPOCK1 for SPARC/Osteonectin-CWCV-kazal-like-domains-proteoglycan).
|
16314830 |
2006 |
Leukemia, T-Cell
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Induction of AKT serine/threonine kinase activity is augmented by the T-cell leukemia-1 (TCL1) oncoprotein through a physical association requiring the AKT pleckstrin homology domain.
|
12009899 |
2002 |
Leukemia, T-Cell
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recently, the proto-oncogene TCL1 (T cell leukemia 1), with a previously unknown physiological function, was shown to interact with the Akt pleckstrin homology domain, enhancing Akt kinase activity; hence, it functions as an Akt kinase coactivator.
|
17360849 |
2007 |
Malaria
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our data establish a dual role of P. berghei P47 in vivo and reinforce the use of this parasite to study the impact of the mosquito immune response on human malaria transmission.
|
28729672 |
2017 |
Malaria
|
0.020 |
Biomarker
|
disease |
BEFREE |
These key functions make Plasmodium P47 an attractive target to disrupt malaria transmission.
|
29229188 |
2017 |